(Q43000770)

12 November 2017

Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

1 reference

Fujita N

1

1 reference

12 November 2017

Kaito M

2

1 reference

12 November 2017

Kai M

3

1 reference

12 November 2017

Sugimoto R

4

1 reference

12 November 2017

Tanaka H

5

1 reference

12 November 2017

Horiike S

6

1 reference

12 November 2017

Konishi M

7

1 reference

12 November 2017

Iwasa M

8

1 reference

12 November 2017

Watanabe S

9

1 reference

12 November 2017

Adachi Y

10

1 reference

12 November 2017

1 July 2006

1 reference

Journal of Viral Hepatitis

12 November 2017

1 reference

12 November 2017

13

1 reference

12 November 2017

7

1 reference

12 November 2017

441-448

1 reference

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Natural history of hepatitis C: its impact on clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Association of hepatitis C virus in human sera with beta-lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Real-time detection system for quantification of hepatitis C virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Paraformaldehyde protects of hepatitis C virus particles during ultracentrifugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

RelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-kappaB and Sp1 actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00718.X

10.1111/J.1365-2893.2005.00718.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference